Systemic lupus, immunosuppressives, COVID-19 vaccination, and antibody response: comment on the article by Petri et al

被引：0
|
作者：
Kleebayoon, Amnuay [1 ]
Wiwanitkit, Viroj [2 ,3 ]
机构：
[1] Private Acad Consultant, Samraong, Cambodia
[2] Chandigarh Univ, Ludhiana, Punjab, India
[3] Joesph Ayobabalola Univ, Ikeji Arakeji, Nigeria
来源：
ARTHRITIS CARE & RESEARCH | 2023年 / 75卷 / 10期
关键词：
D O I：
10.1002/acr.25110
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2224 / 2225
页数：2
相关论文
共 50 条
  • [1] Systemic lupus, immunosuppressives, COVID-19 vaccination, and antibody response: comment on the article by Petri et al Reply
    Petri, Michelle
    Joyce, Daniel
    Haag, Kristin
    Fava, Andrea
    Goldman, Daniel W. W.
    Zhong, Diana
    Xiao, Shaoming
    Milstone, Aaron
    Magder, Laurence S. S.
    [J]. ARTHRITIS CARE & RESEARCH, 2023, 75 (10) : 2225 - 2225
  • [2] Systemic lupus erythematosus myocarditis and COVID-19 vaccination: Comment
    Kleebayoon, Amnuay
    Wiwanitkit, Viroj
    [J]. REUMATOLOGIA CLINICA, 2023, 19 (06): : 349 - 349
  • [3] Effect of Systemic Lupus Erythematosus and Immunosuppressive Agents on COVID-19 Vaccination Antibody Response
    Petri, Michelle
    Joyce, Daniel
    Haag, Kristin
    Fava, Andrea
    Goldman, Daniel W.
    Zhong, Diana
    Xiao, Shaoming
    Milstone, Aaron
    Magder, Laurence S.
    [J]. ARTHRITIS CARE & RESEARCH, 2023, 75 (09) : 1878 - 1885
  • [4] Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al
    Ugarte-Gil, Manuel F.
    Wojdyla, Daniel
    Pons-Estel, Guillermo J.
    Pons-Estel, Bernardo A.
    Alarcon, Graciela S.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70 (12) : 2098 - 2099
  • [5] The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al
    Major, Gabor A. C.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (04): : 1157 - 1158
  • [6] Factors influencing severe COVID-19 in systemic vasculitis patients: comment on the article by Rutherford et al
    Kardas, Riza Can
    Kucuk, Hamit
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 (04) : 726 - 726
  • [7] Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al
    Mathian, Alexis
    Amoura, Zahir
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (02)
  • [8] Is low disease activity sufficient as a target in systemic lupus erythematosus? Comment on the article by Petri et al Reply
    Petri, Michelle
    Magder, Laurence S.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70 (12) : 2099 - 2099
  • [9] The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al Reply
    Merrill, Joan T.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (04): : 1158 - 1158
  • [10] Hydroxychloroquine in systemic lupus erythematosus: comment on the article by Muangchan et al
    Michaud, Martin
    Gaches, Francis
    [J]. ARTHRITIS CARE & RESEARCH, 2016, 68 (07) : 1052 - 1053
12345